Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia
- PMID: 16940426
- PMCID: PMC1785069
- DOI: 10.1182/blood-2006-02-005082
Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia
Abstract
Sickle cell anemia (SS) is highly phenotypically variable, and early predictors of outcome could guide clinical care. To determine whether early vaso-occlusive complications predicted subsequent adverse outcomes in the Dallas Newborn Cohort, we studied all members with SS or sickle-beta0-thalassemia who presented in their first year of life and had 5 years or more of follow-up. We defined 3 potential early predictors: hospitalizations in the first 3 years of life for (1) painful events other than dactylitis, (2) dactylitis, and (3) acute chest syndrome (ACS). We studied the associations of these predictors with the following late adverse outcomes (occurring after the third birthday): death, first overt stroke, use of disease-modifying therapy, and hospitalizations for pain events and ACS. None of the early events predicted death or stroke. Early pain and ACS both predicted a modest, temporary increase in the number of later painful episodes, but early ACS strongly increased the odds of more frequent ACS throughout childhood. Dactylitis had limited utility as a predictor. Although we still lack a useful prognostic framework for young children with SS, those who experience early ACS might be candidates for higher risk interventions to mitigate or cure their disease.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures


Similar articles
-
Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease.Blood. 1995 Jul 15;86(2):776-83. Blood. 1995. PMID: 7606007 Review.
-
Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.Am J Hematol. 2013 Nov;88(11):E261-4. doi: 10.1002/ajh.23531. Epub 2013 Aug 30. Am J Hematol. 2013. PMID: 23828131
-
Prediction of adverse outcomes in children with sickle cell disease.N Engl J Med. 2000 Jan 13;342(2):83-9. doi: 10.1056/NEJM200001133420203. N Engl J Med. 2000. PMID: 10631276
-
Red blood cell transfusions during sickle cell anemia vaso-occlusive crises: a report from the magnesium in crisis (MAGiC) study.Transfusion. 2017 Aug;57(8):1891-1897. doi: 10.1111/trf.14155. Epub 2017 May 12. Transfusion. 2017. PMID: 28500682 Clinical Trial.
-
[Assessment of the use of transfusion therapy and complications in orthopedic surgery in patients with sickle-cell anemia: retrospective study].Transfus Clin Biol. 2003 Apr;10(2):61-6. doi: 10.1016/s1246-7820(03)00021-1. Transfus Clin Biol. 2003. PMID: 12763144 Review. French.
Cited by
-
The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia.Lancet. 2016 Jun 18;387(10037):2545-53. doi: 10.1016/S0140-6736(16)00145-8. Lancet. 2016. PMID: 27353685 Free PMC article. Review.
-
Factors predicting future ACS episodes in children with sickle cell anemia.Am J Hematol. 2014 Nov;89(11):E212-7. doi: 10.1002/ajh.23819. Epub 2014 Aug 27. Am J Hematol. 2014. PMID: 25088663 Free PMC article.
-
Associated factors of acute chest syndrome in children with sickle cell disease in French Guiana.Int J Pediatr. 2014;2014:213681. doi: 10.1155/2014/213681. Epub 2014 Jan 19. Int J Pediatr. 2014. PMID: 24678322 Free PMC article.
-
Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil.Rev Bras Hematol Hemoter. 2011;33(3):207-10. doi: 10.5581/1516-8484.20110055. Rev Bras Hematol Hemoter. 2011. PMID: 23049297 Free PMC article.
-
Value of DNA testing in the diagnosis of sickle-cell anemia in childhood in an environment with a high prevalence of other causes of anemia.J Clin Lab Anal. 2022 Aug;36(8):e24593. doi: 10.1002/jcla.24593. Epub 2022 Jul 12. J Clin Lab Anal. 2022. PMID: 35819088 Free PMC article.
References
-
- Quinn CT, Miller ST. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematol Oncol Clin North Am. 2004;18:1339–1354. - PubMed
-
- Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639–1644. - PubMed
-
- Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11–16. - PubMed
-
- Steinberg MH, Dreiling BJ, Morrison FS, Necheles TF. Mild sickle cell disease; clinical and laboratory studies. JAMA. 1973;224:317–321. - PubMed